Gilead, Cognizant
Cognizant Expands Partnership with Gilead
Gilead is expected to enhance its efficiency through leveraging Cognizant’s expertise in AI and advanced technology applications. By deploying these solutions across the value chain, Cognizant aims to help Gilead achieve significant benefits through a newly optimized financial framework.
Cognizant and Gilead Expand Partnership to Drive Greater Value Through Advanced Technology Applications
Cognizant (NASDAQ: CTSH) has announced an expansion of its longstanding relationship with biopharmaceutical leader Gilead Sciences (NASDAQ: GILD) that aims to unlock even greater value for Gilead as it advances innovations to prevent and treat life-threatening diseases.
Thursday announced that it has expanded its long-standing collaboration with Gilead Sciences (GILD) to enhance cost ...
Gilead Sciences, Inc. (NASDAQ:GILD) develops and markets medicines for HIV, COVID-19, hepatitis, cancer, and other serious conditions. On January 30, Gilead Sciences ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback